| Literature DB >> 35736278 |
Fabrice Noël Hakan Karabulut1, Dhevesh Fomra1, Günther Höfler1, Naveen Ashok Chand1, Gareth Wesley Beckermann1.
Abstract
Electrospun nanofibres excel at air filtration owing to diverse filtration mechanisms, thereby outperforming meltblown fibres. In this work, we present an electrospun polylactide acid nanofibre filter media, FilterLayrTM Eco, displaying outstanding bactericidal and virucidal properties using Manuka oil. Given the existing COVID-19 pandemic, face masks are now a mandatory accessory in many countries, and at the same time, they have become a source of environmental pollution. Made by NanoLayr Ltd., FilterLayrTM Eco uses biobased renewable raw materials with products that have end-of-life options for being industrially compostable. Loaded with natural and non-toxic terpenoid from manuka oil, FilterLayr Eco can filter up to 99.9% of 0.1 µm particles and kill >99% of trapped airborne fungi, bacteria, and viruses, including SARS-CoV-2 (Delta variant). In addition, the antimicrobial activity, and the efficacy of the filter media to filtrate particles was shown to remain highly active following several washing cycles, making it a reusable and more environmentally friendly option. The new nanofibre filter media, FilterLayrTM Eco, met the particle filtration efficiency and breathability requirements of the following standards: N95 performance in accordance with NIOSH 42CFR84, level 2 performance in accordance with ASTM F2100, and level 2 filtration efficiency and level 1 breathability in accordance with ASTM F3502. These are globally recognized facemask and respirator standards.Entities:
Keywords: SARS-CoV-2; electrospun; filter media; filtration; nanofibre; polylactid acid
Year: 2022 PMID: 35736278 PMCID: PMC9227935 DOI: 10.3390/membranes12060571
Source DB: PubMed Journal: Membranes (Basel) ISSN: 2077-0375
Filtration test method requirements.
| Test | Level 1 | Level 2 | Level 3 | |
|---|---|---|---|---|
| ASTM F2299 (PFE) | 95%≤ | 98%≤ | ||
| EN14683 | ≤49 Pa | ≤58.8 Pa | ||
| ASTM F2101 -19 (BFE) | 95%≤ | 98%≤ | ||
| ASTM F2101 (VFE) | 95%≤ | 98%≤ | ||
| ASTM F3502 Filtration at 0.3 µm—60 L/min | 20% £ | 50%≤ | - | |
| ASTM F3502 | 15 mmH2O (147.5 Pa) | 5 mmH2O (49 Pa) | - | |
| NIOSH 42 CFR 84 | N95 | |||
| Breathing resistance | Inhalation—120 L·min−1 | <314 Pa | ΔP < 98 Pa | |
| Exhalation—85 L·min−1 | <245 Pa | |||
Antibacterial activity rating associated with percentage reduction of bacterial growth.
| Antibacterial Activity Value (A) | Efficacy Rating | A Value | Reduction (%) |
|---|---|---|---|
|
| Good Effect Level | 1 | 90 |
| 2 | 99 | ||
| 3 | 99.9 | ||
|
| Excellent Effect Level | 4 | 99.99 |
| 5 | 99.999 |
Antiviral activity rating associated with percentage reduction of virus growth.
| Antiviral Activity Value (Mv) | Efficacy Rating | Mv Value | Reduction (%) |
|---|---|---|---|
|
| Good Effect Level | 1 | 90 |
| 2 | 99 | ||
| 3 | 99.9 | ||
|
| Excellent Effect Level | 4 | 99.9 |
| 5 | 99.999 |
Figure 1(A) Diagram of FilterLayrTM Eco structure spun-bond PLA/PLA electrospun nanofibre/spun-bond PLA; (B) Scanning electron micrograph of nanofibre layer made from PLA; and (C) average fibre distribution of PLA electrospun fibres using Fibraquant image analysis software.
Figure 2Filtration efficiency vs. pressure drop for PLA NF filter media tested in accordance with the following international standards: (A) ASTM F2299 [40], (B) NIOSH 42CFR84 [42] and (C) ASTM F3502 [41].
Pressure drop and filtration efficiency results for PLA NF filter media tested in accordance with ASTM F2299 [40], ASTM F3502 [41] and NIOSH 42CFR84 [42].
| ASTM F2299 | ASTM F3502 | NIOSH 42CFR84 | ||||||
|---|---|---|---|---|---|---|---|---|
| Filtration Efficiency at 100 nm | ΔP | Filtration Efficiency at 300 nm | ΔP Inh. | ΔP Exh. | Filtration Efficiency at 300 nm | ΔP Ex. | ΔP Inh. | |
| 1 | 99.87 | 55.90 | 98.31 | 96.20 | 99.05 | 98.08 | 94.20 | 138.58 |
| 2 | 99.88 | 55.90 | 98.44 | 96.60 | 100.99 | 98.61 | 102.00 | 149.37 |
| 3 | 99.59 | 59.00 | 98.83 | 99.13 | 100.63 | 99.18 | 120.47 | 174.84 |
| 4 | 99.65 | 53.70 | 99.23 | 101.21 | 102.54 | 98.95 | 129.13 | 188.36 |
| 5 | 99.68 | 49.30 | 99.62 | 101.46 | 103.01 | 99.11 | 142.08 | 206.31 |
| 6 | 99.33 | 48.20 | 99.51 | 102.28 | 103.16 | 99.64 | 174.00 | 250 |
| 7 | 99.98 | 53.60 | 100 | 103.12 | 105.21 | 100 | 178.44 | 257.3 |
| 8 | 99.68 | 49.70 | 100 | 185.48 | 266.18 | |||
| 9 | 99.24 | 185.77 | 266.95 | |||||
| 10 | 100 | 189.76 | 273.38 | |||||
| 11 | 100 | 201.14 | 289.63 | |||||
| 12 | 100 | 204.18 | 295.12 | |||||
| 13 | 100 | 205.14 | 295.33 | |||||
Figure 3(left) Antibacterial activity of PLA NF filter media containing manuka triketone (5 wt.%) against S. aureus (ATCC 6538P), E. coli (ATCC 8739) and K. pneumoniae (ATCC 4352) tested according to ISO 20743:2013 [43]. (right) Antiviral activity of PLA NF filter media containing manuka triketone (5 wt.%) against influenza A, human coronavirus 229E and SARS-CoV-2 tested according to ISO 18184:2019 [44]. The arrows point at the inhibition of microbial growth.
Antibacterial reduction rate of PLA NF filter media containing manuka triketone (5 wt.%) against S. aureus (ATCC 6538P), E. coli (ATCC 8739). and K. pneumoniae (ATCC 4352) tested according to ISO 20743:2013 [43]. Reusability following 5 and 10 laundering cycle according to ISO 6330:2013 [49] and ISO 20743:2013, was confirmed for the PLA NF filter media when tested against S. aureus (ATCC 6538P) and K. pneumoniae (ATCC 4352).
| ISO 20743:2013 | |||||||
|---|---|---|---|---|---|---|---|
| 0 Wash | 5 Washes | 10 Washes | 0 Wash | 0 Wash | 5 Washes | 10 Washes | |
| Control | Initial | Initial | Initial | Initial | |||
| Log CFU | 4.69 | 4.69 | 4.83 | 4.80 | |||
| Contacting time (hours) | - | - | - | - | |||
| Control | After contacting | After contacting | After contacting | After contacting | |||
| Log CFU | 7.25 | 7.19 | 7.3 | 7.6 | |||
| Contacting time (hours) | 18 | 18 | 18 | 18 | |||
| Log CFU samples | 2.33 | 2.87 | 3.1 | 3.83 | 4.55 | 4.82 | 5.11 |
| Percentage reduction samples (%) | 99.999 | 99.996 | 99.993 | 99.957 | 99.82 | 99.834 | 99.678 |
| Log reduction samples | 4.92 | 4.38 | 4.15 | 3.36 | 2.75 | 2.78 | 2.49 |
Antiviral reduction rate of PLA NF filter media containing manuka triketone (5 wt.%) against influenza A, human coronavirus 229E and SARS-CoV-2 tested according to ISO 18184:2019 [44].
| ISO 18184:2019 | Influenza A (H1N1) | Human Coronavirus 229E | SARS-CoV-2 |
|---|---|---|---|
| Infective titer test | TCID50 method | TCID50 method | Plaque assay |
| Log(Va) | 5.88 | 4.25 | 3.21 |
| Contacting time (hours) | 2 | 2 | 2 |
| Log(Vc) | 3.88 | 1.5 | 0.70 |
| Antiviral activity value, | 2 | 2.8 | 2.5 |
| Percentage reduction samples (%) | 99 | 99.82 | 99.69 |
Antifungal activity of PLA NF filter media containing manuka triketone (5 wt.%) against Aspergillus niger tested according to ASTM G21 [45]. Note on antifungal rating: 0 no growth, 1 trace of growth (less than 10% coverage), 2 light growth (10–30% coverage), 3 medium growth (30–60% coverage) and 4 heavy growth (60–100% coverage).
| Sub-Samples | Control Specimen | Test Specimen |
|---|---|---|
| Contact time | 28 days | 28 days |
| Rating | 4 | 0 |
| Observed Growth | High Growth | No Growth |